Volume 17, Issue 2

Search all Cancer Chemotherapy and Pharmacology articles

June 1986

Filter by

Volume:

Sort by

Date published:

New to old Old to new

20 articles in this issue

A new triphenylethylene compound, Fc-1157a
Sinikka Kallio
Lauri Kangas
Reijo Toivola
Original Articles Pages: 103 - 108
A new triphenylethylene compound, Fc-1157a
Lauri Kangas
Anna-Liisa Nieminen
Reijo Toivola
Original Articles Pages: 109 - 113
Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide
A. C. M. Kroes
J. Lindemans
J. Abels
Original Articles Pages: 114 - 120
Distribution and tumor penetration properties of a radiosensitizer 2-[¹⁴C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography
G. Akel
P. Benard
G. Soula
Original Articles Pages: 121 - 126
Loss of viability and induction of DNA damage in human leukemic myeloblasts and lymphocytes by m-AMSA
L. W. Brox
A. Belch
E. Pollock
Original Articles Pages: 127 - 132
Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats
A. Lázníčková
M. Lázníček
J. Drobník
Original Articles Pages: 133 - 136
Therapeutic response to taxol of six human tumors xenografted into nude mice
J. Riondel
M. Jacrot
P. Potier
Original Articles Pages: 137 - 142
Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)
Katherine Lu
Niramol Savaraj
Ti Li Loo
Original Articles Pages: 143 - 148
The clinical pharmacology of mitozantrone
John F. Smyth
Janet S. Macpherson
C. Roland Wolf
Original Articles Pages: 149 - 152
Serum and tissue concentrations of doxorubicin after IV administration of doxorubicin or doxorubicin-DNA complex to patients with gastrointestinal cancer
Peter Gunvén
Nils Olof Theve
Curt Peterson
Original Articles Pages: 153 - 156
Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: A randomised, controlled trial
Michael Cullen
David Morgan
Midlands Small Cell Lung Cancer Group
Original Articles Pages: 157 - 160
Treatment of leukemia and myelodysplastic syndromes with orally administered N⁴-palmitoyl-l-β-D-arabinofuranosylcytosine
Ryuzo Ohno
Masami Hirano
Tokai Blood Cancer Study Group
Original Articles Pages: 161 - 164
Adverse effect of cis-diamminedichloroplatinum II (CDDP) on porphyrin metabolism in man
C. G. Alexopoulos
G. Chalevelakis
G. Pallikaris
Original Articles Pages: 165 - 170
Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine
P. Bore
N. Lena
Y. Carcassonne
Original Articles Pages: 171 - 176
The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer
P. E. Lønning
P. M. Ueland
S. Kvinnsland
Original Articles Pages: 177 - 181
Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy
P. K. Buamah
C. Cornell
A. L. Harris
Original Articles Pages: 182 - 184
Renal function in the elimination of oral melphalan in patients with multiple myeloma
C. G. Adair
J. M. Bridges
Z. R. Desai
Original Articles Pages: 185 - 188
Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone
Zalmen A. Arlin
Ellin Berman
Gary Dukart
Original Articles Pages: 189 - 190
Acute and long-term nephrotoxicity of cis-platinum in man
Steffen Groth
H. Nielsen
M. Rørth
Original Articles Pages: 191 - 196
Second Annual Symposium O.O.M.E.R.

Meeting Announcements Pages: A3 - A3

Volume 17, Issue 2

A new triphenylethylene compound, Fc-1157a

A new triphenylethylene compound, Fc-1157a

Enhanced therapeutic effect of methotrexate in experimental rat leukemia after inactivation of cobalamin (vitamin B12) by nitrous oxide

Distribution and tumor penetration properties of a radiosensitizer 2-[¹⁴C] misonidazole (Ro 07-0582), in mice and rats as studied by whole-body autoradiography

Loss of viability and induction of DNA damage in human leukemic myeloblasts and lymphocytes by m-AMSA

Pharmacokinetics and plasma protein binding of two platinum cytostatics CHIP and CBDCA in rats

Therapeutic response to taxol of six human tumors xenografted into nude mice

Clinical pharmacology of 4-demethoxydaunorubicin (DMDR)

The clinical pharmacology of mitozantrone

Serum and tissue concentrations of doxorubicin after IV administration of doxorubicin or doxorubicin-DNA complex to patients with gastrointestinal cancer

Maintenance chemotherapy for anaplastic small cell carcinoma of the bronchus: A randomised, controlled trial

Treatment of leukemia and myelodysplastic syndromes with orally administered N⁴-palmitoyl-l-β-D-arabinofuranosylcytosine

Adverse effect of cis-diamminedichloroplatinum II (CDDP) on porphyrin metabolism in man

Methotrexate-vindesine association in head and neck cancer: modification of methotrexate's hydroxylation in presence of vindesine

The influence of a graded dose schedule of aminoglutethimide on the disposition of the optical enantiomers of warfarin in patients with breast cancer

Serial serum AFP heterogeneity changes in patients with hepatocellular carcinoma during chemotherapy

Renal function in the elimination of oral melphalan in patients with multiple myeloma

Treatment of blastic transformation of chronic myelogenous leukemia with mitoxantrone

Acute and long-term nephrotoxicity of cis-platinum in man

Second Annual Symposium O.O.M.E.R.

Navigation